Relation between agendas of the research community and the research consumer

Oxman, 1996 Gross, 1999, The relation between funding by the National Institutes of Health and the burden of disease, N Engl J Med, 340, 1881, 10.1056/NEJM199906173402406 Rochon, 1994, A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis, Arch Intern Med, 154, 157, 10.1001/archinte.1994.00420020059007 Dickersin, 1992, Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards, J AMA, 267, 374 Chalmers, 1991, The perinatal research agenda: whose priorities?, Birth, 18, 137, 10.1111/j.1523-536X.1991.tb00083.x Chalmers, 1995, What do I want from health research and researchers when I am a patient?, BMJ, 310, 1315, 10.1136/bmj.310.6990.1315 Eachus, 1996, Deprivation and cause specific morbidity: evidence from the Somerset and Avon survey of health, BMJ, 312, 287, 10.1136/bmj.312.7026.287 Egger, 1997, Language bias in randomised controlled trials published in English and German, Lancet, 350, 326, 10.1016/S0140-6736(97)02419-7 Glaser, 1967 Payer, 1988 Grant-Pearce C, Miles I, Hills P. Mismatches in priorities for health research between professionals and consumers. In: Involvement Works-NHS Executive, 1999. Goodman, 1999, Who will challenge evidence based medicine?, J R Coll Physician Lond, 33, 249